Deschloroetizolam (also known as Etizolam-2) is a thienotriazolodiazepine that is the dechlorinated analog of the closely related etizolam. The compound has been sold as a designer drug.
Deschloroetizolam is classified and controlled as a hazardous substance in Sweden as of on October 15, 2015.
Deschloroetizolam was made schedule I at the state level in Alabama on July 15, 2024.